We and others have demonstrated that DEPDC1 acts as a transcription repressor to inhibit the transcription of A20, a negative regulator of the NF-κB signaling pathway in bladder cancer cells and HeLa cells [8, 15]. Here, NFKB1 is linked to urinary bladder cancer.